These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2. Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966 [No Abstract] [Full Text] [Related]
3. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature. Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236 [TBL] [Abstract][Full Text] [Related]
4. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2. Lesort C; Kanitakis J; Donzier L; Jullien D J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e630-e632. PubMed ID: 34131969 [No Abstract] [Full Text] [Related]
5. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series. Russo R; Cozzani E; Micalizzi C; Parodi A Acta Derm Venereol; 2022 May; 102():adv00711. PubMed ID: 35229165 [No Abstract] [Full Text] [Related]
6. Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report. Souaid K; Oulès B; Sohier P; Deschamps L; Aractingi S; Dupin N Acta Derm Venereol; 2021 Nov; 101(11):adv00589. PubMed ID: 34396420 [No Abstract] [Full Text] [Related]
7. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396 [TBL] [Abstract][Full Text] [Related]
8. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination. Temiz SA; Abdelmaksoud A; Dursun R; Vestita M Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629 [No Abstract] [Full Text] [Related]
9. Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees. Bassi A; Mazzatenta C; Sechi A; Cutrone M; Piccolo V J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e497-e498. PubMed ID: 35188988 [No Abstract] [Full Text] [Related]
10. Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology. Rodríguez-Villa Lario A; Vega-Díez D; González-Cañete M; Gómez-Zubiaur A; Pérez-Mesonero R; Bandini M; Polo-Rodríguez I; Vélez-Velázquez D; Trasobares-Marugán L J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e572-e574. PubMed ID: 32531120 [No Abstract] [Full Text] [Related]
11. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains. Poizeau F; Triquet L; Dupuy A Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360 [No Abstract] [Full Text] [Related]
12. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association? Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789 [No Abstract] [Full Text] [Related]
14. A case of onychomadesis associated with chilblain-like lesions after COVID-19 infection. Colonna C; Giacalone S; Zussino M; Monzani NA; Cambiaghi S; Cavalli R J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e668-e669. PubMed ID: 35535454 [No Abstract] [Full Text] [Related]
15. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855 [TBL] [Abstract][Full Text] [Related]
16. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic. Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291 [TBL] [Abstract][Full Text] [Related]
17. A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine? Meara AS; Silkowski M; Quin K; Jarjour W J Rheumatol; 2021 Nov; 48(11):1754. PubMed ID: 34210829 [No Abstract] [Full Text] [Related]
18. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles. Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions. Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097 [TBL] [Abstract][Full Text] [Related]